Esmita is the senior lead research pharmacist at the National Institute of Health Research Health Protection Research Unit (HPRU) in Healthcare Associated Infections and Antimicrobial Resistance. The HPRU is a partnership between Imperial College London, Public Health England, Cambridge University Veterinary School, the Wellcome Trust Sanger Institute and Imperial College Health Partners North West London Academic Health Science Network. She is also a visiting Researcher at Haukeland University Hospital, Bergen Norway, where she is involved in investigating the implementation of the national antibiotic stewardship programme. She is visiting faculty at Amrita Institute of Medical Sciences, Kerala India. As a Global Health Fellow with the Office of the Chief Pharmaceutical Officer for England, Esmita is involved in mentoring and supporting NHS healthcare professionals and healthcare teams across Commonwealth countries in partnerships to tackle antimicrobial resistance. She is an Emerging Leader at the International Society for Infectious Disease and a Fellow of the European Society for Clinical Microbiology and Infectious Diseases.
She is the co-developer of Massive Open Online Courses on antimicrobial stewardship and how to apply social sciences to tackle antimicrobial resistance in collaboration with the British Society for Antimicrobial Chemotherapy.
After completing her post-graduate training in Cambridge University Hospitals and ten years of experience as a clinical pharmacist in hospitals, Esmita began her research career. She is the recipient of the RPSGB Galen Pharmacy Research Award for research into antibiotic dosing and obesity. She is an investigator in a NIHR Invention for Innovation award investigating the development and use of a point of care personalised clinical decision support tool for antimicrobial prescribing. In her academic career the focus of her research has been behaviour change interventions in the field of antimicrobial stewardship and the role of mobile health technologies to influence decision making. She is co-investigator on the ESRC award (2017-2021): Optimising antibiotic use along surgical pathways: addressing antimicrobial resistance and improving clinical outcomes (in England, Scotland, Rwanda, India & South Africa). Esmita completed her Masters (MPharm Hons) in Pharmacy at University College London, and her MSc in Infectious Diseases at LSHTM.
She is an investigator in a National Institute of Health Research Invention for Innovation award investigating the development and use of a point of care personalized clinical decision support tool for antimicrobial prescribing.
Esmita has a degree in Pharmacy from the University of London (MPharm). Following several years of clinical posts at Addenbrooke's Hospital in Cambridge Esmita obtained a MSc in Infectious Diseases from the London School of Hygiene and Tropical Medicine. She was awarded her PhD from Imperial College London in 2018. Previous to joining Imperial as a researcher Esmita held several Clinical posts at the Royal Free Hospital, the North Middlesex Hospital and was the Scientific Secretariat to a Department of Health Scientific Expert Advisory Group.
et al., 2020, COVID-19 and the potential long term impact on antimicrobial resistance, Journal of Antimicrobial Chemotherapy, Vol:75, ISSN:0305-7453, Pages:1681-1684
et al., 2020, New-onset anosmia and ageusia in adult patients diagnosed with SARS-CoV-2 infection., Clinical Microbiology and Infection, ISSN:1198-743X
et al., 2020, A behavioural approach to specifying interventions: what insights can be gained for the reporting and implementation of interventions to reduce antibiotic use in hospitals?, Journal of Antimicrobial Chemotherapy, Vol:75, ISSN:0305-7453, Pages:1338-1346